FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
NMFS closes the Atlantic bluefin tuna angling category trophy fishery in Southern New England for 2026 for fish measuring 73 inches or greater curved fork length.
Centers for Medicare & Medicaid Services launches a matching program with the Department of Veterans Affairs to verify eligibility for insurance affordability programs under the Affordable Care Act.
CDC seeks public comment on a data collection for mChoice, a research study testing tailored provider training and adherence support to improve PrEP uptake among young men who have sex with men in high-priority settings.
CDC seeks public comment through [date] on the Expanding PrEP in Communities of Color (EPICC) data collection effort, which supports shared decision-making training and evaluation for preexposure prophylaxis providers serving diverse populations.
FDA submitted a proposed information collection to OMB for Paperwork Reduction Act review regarding formal hearing administrative procedures and practices.
FDA seeks 60 days of public comment on information collection requirements for Biologics License Applications under the Paperwork Reduction Act; deadline for comments is 60 days from Federal Register publication.
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
CMS proposes 2027 Medicare home health payment rate updates, case-mix recalibrations, quality reporting changes, and DMEPOS enrollment and benefit modifications affecting home health agencies and DME suppliers.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
